Inventor

VANKAYALAPATI HARIPRASAD

US52 patents

⚠️ This page may combine multiple inventors who share the name “VANKAYALAPATI HARIPRASAD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

VANKAYALAPATI HARIPRASAD

ARRIEN PHARMACEUTICALS LLC

Substituted 5-(pyrazin-2-yl)-1H-pyrazolo [3, 4-B] pyridine and pyrazolo [3, 4-B] pyridine derivatives as protein kinase inhibitors

Substituted 2,3-dihydro-1H-inden-1-one retinoic acid-related orphan nuclear receptor antagonists for treating multiple sclerosis

Substituted 1 H-pyrrolo [2, 3-b] pyridine and 1 H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors

Substituted 1H-pyrrolo [2, 3-b] pyridine and 1H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors

Substituted 1H-pyrrolo [2, 3-b] pyridine and 1H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors

Substituted pyrrolo[2,3-b]pyridines as ITK and JAK inhibitors

Substituted pyrimidines for inhibiting embryonic leucine zipper kinase activity

Substituted 2, 3-dihydro-1H-inden-1-one retinoic acid-related orphan nuclear receptor antagonists for treating multiple sclerosis

Substituted 2,3-dihydro-1H-inden-1-one Retinoic acid-related orphan nuclear receptor antagonists for treating multiple sclerosis

Substituted 2,3-dihydro-1H-inden-1-one retinoic acid-related orphan nuclear receptor antagonists for treating multiple sclerosis

Substituted 5-(pyrazin-2-yl)-1H-pyrazolo [3, 4-b] pyridine and pyrazolo [3, 4-b] pyridine derivatives as protein kinase inhibitors

Substituted pyrrolo[2,3-b]pyrazines and substituted pyrazolo[3,4-b]pyridines as ITK and JAK kinase inhibitors

Substituted 5-(pyrazin-2-yl)-1H-pyrazolo [3, 4-b] pyridine and pyrazolo [3, 4-b] pyridine derivatives as protein kinase inhibitors

BEARSS DAVID J

Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors

Substituted N-phenylpyrimidin-2-amine analogs as inhibitors of the Axl kinase

Imidazo[1,2-B]pyridazine and pyrazolo[1 .5-A]pyrimidine derivatives and their use as protein kinase inhibitors

Pharmaceutical formulations comprising salts of a protein kinase inhibitor and methods of using same

Oxo-imidazolyl compounds

Substituted 3-(1H-benzo[d]imidazol-2-yl)-1H-indazole analogs as inhibitors of the PDK1 kinase

SUPERGEN INC

Imidazo[1,2-beta]pyridazine and pyrazolo[1,5-alpha]pyrimidine derivatives and their use as protein kinase inhibitors

Axl kinase inhibitors

Quinoline derivatives for modulating DNA methylation

Quinoline derivatives for modulating DNA methylation

Pharmaceutical formulations comprising salts of a protein kinase inhibitor and methods of using same

UNIV UTAH RES FOUND

Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors

Substituted N-(3-pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors

Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors

Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors

Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors

UNIV ARIZONA

Substituted tricyclic compounds as protein kinase inhibitors

Substituted tricyclic compounds as protein kinase inhibitors

Substituted tricyclic compound as protein kinase inhibitors

Substituted tricyclic compounds as protein kinase inhibitors

CONVERGENE LLC

Methods and compositions for inhibition of bromodomain-containing proteins

Methods and compositions for inhibition of bromodomain-containing proteins

Methods and compositions for inhibition of bromodomain-containing proteins

STINGRAY THERAPEUTICS INC

Quinoline and quinazoline compounds and methods of use thereof

Substituted-3H-imidazo[4,5-c]pyridine and 1H-pyrrolo[2,3-c]pyridine series of novel Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1) and stimulator for interferon genes (STING) modulators as cancer immunotherapeutics

Substituted-3H-imidazo [4,5-c] pyridine and 1H-pyrrolo[2,3-c]pyridine series of novel ectonucleotide pyrophosphatase/phosphodiesterase-1 (ENPP1) and stimulator for interferon genes (STING) modulators as cancer immunotherapeutics

VANKAYALAPATI HARIPRASAD

Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors

Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors

Substituted 5-(pyrazin-2-yl)-1H-pyrazolo [3, 4-B] pyridine and pyrazolo [3, 4-B] pyridine derivatives as protein kinase inhibitors

TOLERO PHARMACEUTICALS INC

JAK2 and ALK2 inhibitors and methods for their use

JAK1 and ALK2 inhibitors and methods for their use

UNIV ARIZONA STATE

Protein kinase inhibitors

HURLEY LAURENCE H

Substituted tricyclic compounds as protein kinase inhibitors

UNIV UTAH

Substituted-1H-benzo[d]imidazole series compounds as lysine-specific demethylase 1 (LSD1) inhibitors

BETA CAT PHARMACEUTICALS INC

Anthracene-9, 10-dione dioxime compound prodrugs and their uses

THE TRANSLATIONAL GENOMICS RES INSTITUTE

Phosphonate conjugates and uses thereof

BIOLEXIS THERAPEUTICS INC

CDK9 inhibitors